Cipla allowed to sell Eli Lilly's weight-loss drug. (Photo source: NDTV Profit) Show Quick Read Summary is AI Generated. Newsroom Reviewed

Eli Lilly's blockbuster weight loss drug has found a market in India under the brand name Yurpeak after the company signed a deal with Indian drug maker Cipla on Thursday.

As per news agency Reuters , the companies have agreed to market the drug under as a separate brand in the country. The agreement allows Cipla to sell 'Yurpeak' after it has been manufactured by Lilly.

Similar to Lilly's Mounjaro Kwikpen, the drug will be available as a once a week, pre-filled injector pen, giving healthcare specialists space to devise personal plans according to the needs of individual patients.

The injector pen will be available in the following six doses

See Full Page